129 related articles for article (PubMed ID: 38892491)
21. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
Jayasooriya N; Baillie S; Blackwell J; Bottle A; Petersen I; Creese H; Saxena S; Pollok RC;
Aliment Pharmacol Ther; 2023 Mar; 57(6):635-652. PubMed ID: 36627691
[TBL] [Abstract][Full Text] [Related]
22. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease.
Meister D; Ghosh S
World J Gastroenterol; 2005 Dec; 11(47):7466-72. PubMed ID: 16437718
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
24. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
[TBL] [Abstract][Full Text] [Related]
25. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
26. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
27. Diet, Food, and Nutritional Exposures and Inflammatory Bowel Disease or Progression of Disease: an Umbrella Review.
Christensen C; Knudsen A; Arnesen EK; Hatlebakk JG; Sletten IS; Fadnes LT
Adv Nutr; 2024 May; 15(5):100219. PubMed ID: 38599319
[TBL] [Abstract][Full Text] [Related]
28. Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies.
Reznikov EA; Suskind DL
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771373
[TBL] [Abstract][Full Text] [Related]
29. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
30. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
[TBL] [Abstract][Full Text] [Related]
31. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
[TBL] [Abstract][Full Text] [Related]
32. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
33. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India.
Mohan N; Deswal S; Bhardwaj A
Indian J Gastroenterol; 2024 Feb; 43(1):208-214. PubMed ID: 37943479
[TBL] [Abstract][Full Text] [Related]
34. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
[TBL] [Abstract][Full Text] [Related]
35. Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
Šimurina M; de Haan N; Vučković F; Kennedy NA; Štambuk J; Falck D; Trbojević-Akmačić I; Clerc F; Razdorov G; Khon A; Latiano A; D'Incà R; Danese S; Targan S; Landers C; Dubinsky M; ; McGovern DPB; Annese V; Wuhrer M; Lauc G
Gastroenterology; 2018 Apr; 154(5):1320-1333.e10. PubMed ID: 29309774
[TBL] [Abstract][Full Text] [Related]
36. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
37. Differences in Dietary Patterns of Adolescent Patients with IBD.
Kikut J; Skonieczna-Żydecka K; Sochaczewska D; Kordek A; Szczuko M
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578996
[TBL] [Abstract][Full Text] [Related]
38. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
39. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
Menesy A; Hammad M; Aref S; Abozeid FAM
BMC Gastroenterol; 2024 Apr; 24(1):135. PubMed ID: 38622545
[TBL] [Abstract][Full Text] [Related]
40. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
